Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista Systemic allergic contact dermatitis caused by tea tree oil in a cream for treatment of molluscum contagiosum Autores: Navarro-Trivino, FJ; Prados-Carmona, A; Ruiz-Villaverde, R Tildrakizumab: Efficacy, Safety and Survival in Mid-Term (52 Weeks) in Three Tertiary Hospitals in Andalucia (Spain) Autores: Ruiz-Villaverde, R; Fernandez-Freire, LR; Font-Ugalde, P; Galan-Gutierrez, M Successful treatment of follicular mucinosis with low-dose UVA1 phototherapy Autores: Gil-Villalba, A; de la Torre-Gomar, FJ; Navarro-Trivino, FJ; Ruiz-Villaverde, R Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series Autores: Ruiz-Villaverde, R; Rodriguez-Fernandez-Freire, L; Armario-Hita, JC; Perez-Gil, A; Galan-Gutierrez, M Super-Responders in Moderate-Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives Autores: Ruiz-Villaverde, R; Vasquez-Chinchay, F; Rodriguez-Fernandez-Freire, L; Armario-Hita, JC; Perez-Gil, A; Galan-Gutierrez, M Risankizumab: Efficacy, Safety, and Survival in the Mid-Term (52 Weeks) in Real Clinical Practice in Andalusia, Spain, According to the Therapeutic Goals of the Spanish Psoriatic Guidelines Autores: Ruiz-Villaverde, R; Rodriguez-Fernandez-Freire, L; Perez-Gil, A; Font-Ugalde, P; Galan-Gutierrez, M Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment Autores: Linares-Gonzalez, L; Lozano-Lozano, I; Gutierrez-Rojas, L; Ruiz-Villaverde, R; Lozano-Lozano, M < 1 2 … 516 517 518 … 1.504 1.505 >